Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis

Archives of Neurology
M P GormanTanuja Chitnis

Abstract

To investigate whether or not the disparity in disease progression in those with pediatric-onset compared with adult-onset multiple sclerosis (MS) is due to differences in relapse rates. Inception cohort. Mean follow-up times were 3.67 (standard deviation, 1.64) and 3.98 (standard deviation, 1.17) years in the pediatric and adult groups, respectively. Comprehensive MS centers. Patients with relapsing-remitting MS who were seen at the pediatric and adult MS centers at Massachusetts General and Brigham and Women's Hospitals, respectively, 12 months or less from onset of first symptom in July 2001 or later and were followed up for 12 months or longer. One hundred ten patients with adult-onset and 21 patients with pediatric-onset MS were included. Three eligible patients with adult-onset MS were excluded owing to incomplete records. Annualized relapse rates were compared between pediatric-onset and adult-onset patients using the proportional means model. The annualized relapse rate in the pediatric-onset group was significantly higher than that in the adult-onset group (1.13 vs 0.40; P < .001) with an adjusted rate ratio of 2.81 (95% confidence interval, 2.07-3.81). When we controlled for time spent undergoing disease-modifying tre...Continue Reading

Citations

Dec 3, 2013·Autoimmune Diseases·Joaquin A Pena, Timothy E Lotze
Apr 24, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Riley Bove, Tanuja Chitnis
Apr 30, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Tanuja Chitnis
May 17, 2014·Neurodegenerative Disease Management·Joy B ParrishBianca Weinstock-Guttman
Aug 4, 2012·AJNR. American Journal of Neuroradiology·M S VishwasT Chitnis
Dec 12, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Tanuja Chitnis
Nov 15, 2013·BMC Neurology·Tanuja ChitnisUNKNOWN U.S. Network of Pediatric MS Centers of Excellence
Jan 13, 2012·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Brian C HealyBonnie I Glanz
Jan 1, 2014·Clinical Neurology and Neurosurgery·Silvia N Tenembaum
Apr 15, 2009·Current Treatment Options in Neurology·Emmanuelle Waubant, Dorothee Chabas
Apr 24, 2009·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Angelo GhezziUNKNOWN ITEMS (Immunomodulatory Treatment of Early-onset MS) Group
Oct 5, 2010·Journal of Medical Economics·Benjamin J ChastekMaria V Lopez-Bresnahan
Oct 30, 2015·Expert Review of Neurotherapeutics·Giovanna VitalitiRaffaele Falsaperla
Apr 12, 2016·Multiple Sclerosis and Related Disorders·Jamie McDonaldEmmanuelle Waubant
Nov 26, 2015·Journal of Neurology·Jonatan SalzerAnders Svenningsson
Dec 25, 2013·Seminars in Pediatric Neurology·Chia-Ching John Lin, Benjamin Deneen
Oct 27, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·J Nicholas Brenton, Brenda L Banwell
Mar 22, 2016·Pediatric Neurology·Naila Makhani, Teri Schreiner
Dec 17, 2015·Current Problems in Pediatric and Adolescent Health Care·Sona Narula
Apr 24, 2013·Neuroimaging Clinics of North America·Leonard H VerheyBrenda Banwell
Jul 15, 2015·European Journal of Pediatrics·Silvia Dell'AvventoStefano Sotgiu
Jan 1, 2012·Multiple Sclerosis and Related Disorders·Brenda Banwell
Oct 27, 2012·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·Deborah B Spiro
Mar 29, 2011·Neurologic Clinics·Tanuja ChitnisEmmanuelle Waubant
Apr 12, 2011·Neuroimaging Clinics of North America·L Celso Hygino da CruzFrederik Barkhof
May 18, 2010·Clinical Neurology and Neurosurgery·Silvia N Tenembaum
Sep 19, 2015·Pediatric Neurology·Raed AlroughaniJasem Al-Hashel
Jun 25, 2009·Developmental Medicine and Child Neurology·Richard E Appleton, Mike Boggild
Aug 29, 2012·Annals of Neurology·Yair SadakaUNKNOWN Canadian Pediatric Demyelinating Disease Network
Dec 18, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·B HuppkeP Huppke
Aug 12, 2014·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·K HuhnD-H Lee
Jan 16, 2013·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Katelyn DonohueRobert Zivadinov
Jan 23, 2015·Annals of Neurology·Sabine PfeifenbringWolfgang Brück
Jan 29, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·David Vargas-LowyTanuja Chitnis
Feb 19, 2010·Expert Opinion on Pharmacotherapy·Nancy L KuntzUNKNOWN Network of US Pediatric Multiple Sclerosis Centers
Jan 13, 2015·The Cerebellum·Katrin WeierTill Sprenger
May 27, 2015·Multiple Sclerosis and Related Disorders·Molly NickersonRuth Ann Marrie
Mar 7, 2015·La Presse médicale·Sona Narula, Brenda Banwell
Apr 17, 2015·Multiple Sclerosis and Related Disorders·L A BensonT Chitnis
Jun 4, 2013·The Journal of Pediatrics·Keith Van Haren, Emmanuelle Waubant
Feb 15, 2015·Current Treatment Options in Neurology·Sona NarulaBrenda Banwell
Nov 13, 2013·BMC Neurology·Silvia MessinaTanuja Chitnis
Nov 17, 2015·Neurology. Neuroimmunology and Neuroinflammation·Dalia L RotsteinTanuja Chitnis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved